3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
2
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Venous Thromboembolism
2
Pulmonary Embolism
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Embolism
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
apixaban
10
Rivaroxaban
5
Aspirin
4
Enoxaparin
3
abelacimab
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Dalteparin
2
ribociclib
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
edoxaban
1
abemaciclib
1
Rosuvastatin Calcium
1
N(4)-oleylcytosine arabinoside
1
Educational Status
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Heparin, Low-Molecular-Weight
×
1 year
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled